Showing results (1851-1860 of 1,988) with videos related to
Sort By:
Pageof 199
The AAPS Journal|June 16, 2010
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technologyClaudia Fredolini, Francesco Meani, Alessandra Luchini, et al.Arthritis and Rheumatism|March 8, 2005
A serum proteomic approach to gauging the state of remission in Wegener's granulomatosisJohn H Stone, Vinodh N Rajapakse, Gary S Hoffman, et al.ACS Medicinal Chemistry Letters|January 20, 2018
Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 AntagonistsRobert J Wilson, Edgars Jecs, Eric J Miller, et al.Critical Care Medicine|January 18, 2018
Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic EncephalopathyEric Michael Liotta, Anna L Romanova, Bryan D Lizza, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2022
Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularizationIrina Heid, Marija Trajkovic-Arsic, Fabian Lohöfer, et al.Cancer Research|March 15, 1997
Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) geneL V Debelenko, M R Emmert-Buck, P Manickam, et al.Journal of Medicinal Chemistry|September 20, 2008
Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonistsYesim A Tahirovic, Matthew Geballe, Ewa Gruszecka-Kowalik, et al.Journal of Medicinal Chemistry|April 21, 2025
Thienopyrimidinone Derivatives as a GluN2B/C/D Biased, Positive Allosteric Modulator of the N-Methyl-d-Aspartate ReceptorRussell G Fritzemeier, Nicholas S Akins, Paul J Arcoria, et al.ACS Medicinal Chemistry Letters|May 19, 2016
Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor PropertiesEric J Miller, Suzanne G Mays, Mark T Baillie, et al.Breast Cancer Research : BCR|December 3, 2020
Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detectionClaudia Fredolini, Khyatiben V Pathak, Luisa Paris, et al.Pageof 199